Eric Bjerkholt
Director of Finance/CFO at MIRUM PHARMACEUTICALS, INC.
Net worth: 635 637 $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Obi Greenman | M | 57 | 29 years | |
| Michael Grey | M | 71 | 6 years | |
| Christopher Peetz | M | 45 | 6 years | |
| Rachel Leheny | M | 60 | 5 years | |
| Lori L. Roll | F | - | 32 years | |
| Michael Dunn | M | 68 | 10 years | |
| David Woodhouse | M | 54 | 4 years | |
| Daniel Swisher | M | 61 | 13 years | |
| Timothy Kutzkey | M | 49 | 8 years | |
| Craig Parker | M | 63 | 6 years | |
| Laurence Corash | M | 80 | 33 years | |
| William Fairey | M | 59 | 3 years | |
| Sona Saira Ramasastry | F | 48 | 2 years | |
| Kevin Green | M | 52 | 18 years | |
| Vivek K. Jayaraman | M | 49 | 8 years | |
| Sudarshan Hebbar | M | 59 | 9 years | |
| Hua Shan | M | 63 | 2 years | |
| Anna Berkenblit | M | 54 | 6 years | |
| Ann Lucena | F | 37 | 3 years | |
| Mary Haak-Frendscho | M | 67 | 3 years | |
| Shao Lee Lin | M | 57 | 3 years | |
| Charles Williams | M | 46 | 4 years | |
| Alicia Goodman | F | - | 5 years | |
| Lon Cardon | M | - | 2 years | |
| Peter Radovich | M | 46 | 4 years | |
| Sophie Kornowski-Bonnet | M | 61 | 6 years | |
| Jami Nachtsheim | F | 65 | 5 years | |
| Allan Shaw | M | 59 | 1 years | |
| Carol Moore | F | 74 | 16 years | |
| Eric Roberts | M | 59 | 4 years | |
| Timothy Walbert | M | 57 | 1 years | |
| Robert Wilson | M | 83 | 1 years | |
| Fred Middleton | M | 74 | 4 years | |
| Frank R. Witney Witney | M | 70 | 10 years | |
| Patrick Heron | M | 53 | 6 years | |
| Kenneth Stauderman | M | 71 | 17 years | |
| Laura Brege | F | 66 | 5 years | |
| Mace Rothenberg | M | 67 | 3 years | |
| Laurent Fischer | M | 60 | 5 years | |
| Timothy Moore | M | 62 | 6 years | |
| Gail Schulze | F | 72 | 17 years | |
| Christopher Chai | M | 58 | 3 years | |
| Suzanne Margerum | F | - | 23 years | |
| Richard Benjamin | M | 64 | 9 years | |
| Raven Jaeger | F | 46 | 1 years | |
| Matthew Notarianni | M | - | - | |
| Maria Lacerca-Allen | M | 57 | 4 years | |
| Daniel Geffken | M | 67 | 1 years | |
| Erin Osborne Murphy | M | - | 4 years | |
| Joanne Quan | M | 60 | - | |
| Travis Wilson | M | - | 6 years | |
| Erin Campany | F | 57 | 2 years | |
| John Dunn | M | 72 | 1 years | |
| Paul K. Ross | M | - | 4 years | |
| Pamela Vig | M | 53 | 6 years | |
| Douglas T. Sheehy | M | 57 |
Aimmune Therapeutics UK Ltd.
 Aimmune Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Stallergenes Greer Ltd., Aimmune Therapeutics UK Ltd. is a pharmaceutical company that manufactures pharmaceutical products. The private company is based in Cheltenham, UK. Aimmune Therapeutics was founded in 2015. | - |
| Lara Krupka-Longpre | F | 54 | 6 years | |
| Andrew McKibben | M | - | - | |
| Nina Mufti | M | - | 17 years | |
| Chrystal Menard | F | 53 | 12 years | |
| Andrew Cunningham | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Dayton Misfeldt | M | 50 | 11 years | |
| Steven Ketchum | M | 59 |
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | 19 years |
| Andrew Oxtoby | M | 50 | - | |
| Ian John Massey | M | 73 |
StemCells, Inc.
 StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 1 years |
| Stephen Dilly | M | 64 | 4 years | |
| Ken Stratton | M | 55 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 14 years |
| Jayson Dallas | M | 56 | 2 years | |
| Martin M. McGlynn | M | 78 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 15 years |
| Eric Dobmeier | M | 55 | 3 years | |
| Rodney Young | M | 61 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 8 years |
| Ernest Mario | M | 85 |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | 1 years |
| Mahesh Krishnan | M | 53 | - | |
| Parvinder S. Hyare | M | - | 7 years | |
| Timothy Bruce Anderson | M | 77 | 18 years | |
| Michelle Griffin | F | 58 | 3 years | |
| Stephen Nava | M | - | - | |
| Brett K. Haumann | M | 54 | - | |
| Steve Carchedi | M | 62 | 8 years | |
| Jerel Davis | M | 47 | 5 years | |
| Geoffrey Parker | M | 59 | 1 years | |
| Jennifer A. Troia | F | - | 12 years | |
| Dolca Thomas | M | 53 | 3 years | |
| Stacey Seltzer | F | 47 | 5 years | |
| Roger Perlmutter | M | 71 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | 13 years |
| Maria Millan | M | - |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | - |
| Mark Iwicki | M | 57 | 5 years | |
| Stephen Huhn | M | 63 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | - |
| John Kozarich | M | 74 | 8 years | |
| Homer Pearce | M | 71 | 15 years | |
| Bhaskar Chaudhuri | M | 69 | 8 years | |
| Ross Haghighat | M | 60 | 14 years | |
| James A. Wells | M | 73 | 10 years | |
| Robert Thomas | M | 62 | 11 years | |
| Kathryn Falberg | F | 63 | 5 years | |
| David Greenwood | M | 72 | 8 years | |
| Ronald Eastman | M | 71 | 11 years | |
| David Stump | M | 74 | 15 years | |
| Srini Akkaraju Akkaraju | M | 56 | 4 years | |
| Andrew King | M | 44 | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 99 | 99.00% |
| United Kingdom | 1 | 1.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Eric Bjerkholt
- Personal Network
